Skip to content

The Significance of Funguria in Hospitalized Patients

The Significance of Funguria in Hospitalized Patients (FACES)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00787085
Acronym
FACES
Enrollment
919
Registered
2008-11-07
Start date
2001-09-30
Completion date
2006-02-28
Last updated
2008-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Tract Infections

Keywords

Funguria, Epidemiology, Urinary Tract Infections

Brief summary

This investigation is a epidemiologic case-control study of the risk factors associated with nosocomial funguria (fungi in the urine).

Detailed description

A recent large multi-center national surveillance survey of almost 5000 nosocomial (hospital based) urine isolates from medical intensive care units demonstrated that fungi comprised nearly 40% of urine isolates. Little is known about distinguishing fungi that cause colonization from those causing infection. The objective of this study is to define the epidemiology of nosocomial funguria and natural history of patients that develop funguria while hospitalized. Patients who may have eligible for this study will be identified from microbiology laboratory specimens at the Harbor-UCLA Medical Center and Cedars-Sinai Medical Center.

Interventions

None listed

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)
CollaboratorNIH
Cedars-Sinai Medical Center
CollaboratorOTHER
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients hospitalized at least 12 hours of any age (\< 1 day to \> 100 years of age) AND a urine or blood culture positive for fungi, OR urine culture negative for fungi (control group)

Exclusion criteria

* Patients already surveyed for funguria during current hospitalization and patients already being followed for recognized funguria

Design outcomes

Primary

MeasureTime frame
FunguriaHospitalization day 0, 3, 7, 14, and every 7 days thereafter until hospital discharge or death

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026